BE641880A - - Google Patents

Info

Publication number
BE641880A
BE641880A BE641880A BE641880A BE641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A
Authority
BE
Belgium
Application number
BE641880A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE641880A publication Critical patent/BE641880A/xx

Links

BE641880A 1962-12-27 1963-12-27 BE641880A (enExample)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP5741963 1963-10-29
JP6427663 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
BE641880A true BE641880A (enExample) 1964-04-16

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
BE641880A BE641880A (enExample) 1962-12-27 1963-12-27

Country Status (5)

Country Link
BE (1) BE641880A (enExample)
FR (1) FR3150M (enExample)
GB (1) GB1080599A (enExample)
LU (1) LU45106A1 (enExample)
NL (1) NL302572A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
PT2319581E (pt) 2004-11-26 2015-06-30 Ucl Business Plc Composições compreendendo ornitina e fenilacetato ou fenilbutirato para tratamento de encefalopatia hepática
CN106810464B (zh) 2009-04-03 2019-01-22 欧塞拉治疗有限公司 L-鸟氨酸苯乙酸盐及其制备方法
ES2517340T3 (es) 2009-06-08 2014-11-03 Ucl Business Plc Tratamiento de la hipertensión portal usando L-ornitina y fenilacetato
EP2625162B1 (en) 2010-10-06 2019-03-13 Ocera Therapeutics, Inc. Methods of making l-ornithine phenyl acetate
KR20230018526A (ko) 2014-11-24 2023-02-07 유씨엘 비즈니스 리미티드 암모니아-저감 치료를 이용한 간성상세포 활성화와 연관된 질병의 치료
JP6990170B2 (ja) 2015-08-18 2022-01-12 オセラ セラピューティクス, インコーポレイテッド L-オルニチンをフェニルアセテートおよびフェニルブチレートのうちの少なくとも1つと組み合わせて用いる筋肉喪失の治療および予防
MX389665B (es) 2017-05-11 2025-03-20 Ocera Therapeutics Inc Procesos para producir fenilacetato de l-ornitina

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
FR3150M (fr) 1965-02-22
NL302572A (enExample)
GB1080599A (en) 1967-08-23
LU45106A1 (enExample) 1964-02-24

Similar Documents

Publication Publication Date Title
BE628342A (enExample)
BE627637A (enExample)
BE617009A (enExample)
BE621602A (enExample)
BE626773A (enExample)
BE629928A (enExample)
BE628220A (enExample)
BE625094A (enExample)
BE627867A (enExample)
BE638142A (enExample)
BE624456A (enExample)
BE628207A (enExample)
BE621944A (enExample)
BE627892A (enExample)
BE628524A (enExample)
BE626900A (enExample)
BE628409A (enExample)
BE626913A (enExample)
BE627212A (enExample)
BE624361A (enExample)
BE612847A (enExample)
BE617648A (enExample)
BE627044A (enExample)
BE629956A (enExample)
BE628353A (enExample)